Pricing Log in Create free account

Adagene Inc. Sponsored ADR (ADAG) vs Zentalis Pharmaceuticals, Inc. (ZNTL)

Adagene Inc. Sponsored ADR and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. Adagene Inc. Sponsored ADR and Zentalis Pharmaceuticals, Inc. are of similar size ($166.6M and $161.8M). Across the 7 metrics below, Adagene Inc. Sponsored ADR leads on 5 and Zentalis Pharmaceuticals, Inc. on 2.

Valuation

Metric ADAG ZNTL Biotechnology median
P/E — n/m 10.26
P/S — n/m 9.18
P/B n/m 0.85 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.34 0.65
EV/Sales n/m n/m 8.98
Earnings yield — (114.04%) (34.89%)
Free cash flow yield 0.00% (104.95%) (24.52%)

Profitability

Metric ADAG ZNTL Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (66.75%) (50.12%)
Return on assets 0.00% (49.22%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADAG ZNTL Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 49.15% 18.03% 29.88%
Revenue growth, 5-year CAGR 61.38% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADAG ZNTL Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 5.02 4.82 4.89
Net debt to EBITDA 3.46 1.59 1.01

Dividend

Metric ADAG ZNTL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ADAG ZNTL Biotechnology median
Market cap 161.81m 166.63m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack